Saad Mark E 4
4 · Axsome Therapeutics, Inc. · Filed Mar 6, 2023
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-02+2,224→ 2,224 totalExercise: $65.32From: 2023-03-02Exp: 2033-03-01→ Common Stock (2,224 underlying)
Footnotes (1)
- [F1]Represents 2,224 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable.